While there is some evidence that the 5-HT7 receptor system may be a potential target for treating mood and anxiety disorders, many agents included in the review also bind to other receptors. Further research is needed using drugs that bind specifically to 5-HT7 receptors to examine treatment proof of concept further.
No takes yet. Share an insight, caveat, or question.
Gottlieb et al. (2023) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: